225 related articles for article (PubMed ID: 7882331)
1. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells.
Zhou BS; Hsu NY; Pan BC; Doroshow JH; Yen Y
Cancer Res; 1995 Mar; 55(6):1328-33. PubMed ID: 7882331
[TBL] [Abstract][Full Text] [Related]
2. Determination of deoxyribonucleoside triphosphate pool sizes in ribonucleotide reductase cDNA transfected human KB cells.
Zhou BS; Ker R; Ho R; Yu J; Zhao YR; Shih J; Yen Y
Biochem Pharmacol; 1998 May; 55(10):1657-65. PubMed ID: 9634002
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a hydroxyurea-resistant human KB cell line with supersensitivity to 6-thioguanine.
Yen Y; Grill SP; Dutschman GE; Chang CN; Zhou BS; Cheng YC
Cancer Res; 1994 Jul; 54(14):3686-91. PubMed ID: 7518343
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA.
Chen S; Zhou B; He F; Yen Y
Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):111-6. PubMed ID: 10805162
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential.
Zhou BS; Tsai P; Ker R; Tsai J; Ho R; Yu J; Shih J; Yen Y
Clin Exp Metastasis; 1998 Jan; 16(1):43-9. PubMed ID: 9502076
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.
Kuo ML; Hwang HS; Sosnay PR; Kunugi KA; Kinsella TJ
Cancer J; 2003; 9(4):277-85. PubMed ID: 12967138
[TBL] [Abstract][Full Text] [Related]
8. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
Moscow JA; Townsend AJ; Cowan KH
Mol Pharmacol; 1989 Jul; 36(1):22-8. PubMed ID: 2747627
[TBL] [Abstract][Full Text] [Related]
9. Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.
Ask A; Persson L; Rehnholm A; Frostesjö L; Holm I; Heby O
Cancer Res; 1993 Nov; 53(21):5262-8. PubMed ID: 8221660
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
Albert DA; Nodzenski E; Yim G; Kowalski J
J Cell Physiol; 1990 May; 143(2):251-6. PubMed ID: 2159014
[TBL] [Abstract][Full Text] [Related]
11. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
Carter GL; Cory JG
Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
[TBL] [Abstract][Full Text] [Related]
12. Increased ribonucleotide reductase activity in hydroxyurea-resistant mosquito cells.
Gerenday A; Shih KM; Herman CC; Fallon AM
Arch Insect Biochem Physiol; 2001; 46(1-2):19-25. PubMed ID: 11276057
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms responsible for the drug-induced posttranscriptional modulation of ribonucleotide reductase levels in a hydroxyurea-resistant mouse L cell line.
McClarty GA; Chan AK; Choy BK; Thelander L; Wright JA
Biochemistry; 1988 Sep; 27(19):7524-31. PubMed ID: 3061459
[TBL] [Abstract][Full Text] [Related]
14. Amplification of the genes for both components of ribonucleotide reductase in hydroxyurea resistant mammalian cells.
Hurta RA; Wright JA
Biochem Biophys Res Commun; 1990 Feb; 167(1):258-64. PubMed ID: 2178608
[TBL] [Abstract][Full Text] [Related]
15. Quantification of ribonucleotide reductase expression in wild-type and hydroxyurea-resistant cell lines employing in situ reverse transcriptase polymerase chain reaction and a computerized image analysis system.
Wadler S; Zhang H; Cammer M; Hu XP
Anal Biochem; 1999 Feb; 267(1):24-9. PubMed ID: 9918651
[TBL] [Abstract][Full Text] [Related]
16. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity.
Schecter RL; Alaoui-Jamali MA; Woo A; Fahl WE; Batist G
Cancer Res; 1993 Oct; 53(20):4900-6. PubMed ID: 8402679
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of M1 and M2 components and drug-induced posttranscriptional modulation of ribonucleotide reductase in a hydroxyurea-resistant mouse cell line.
McClarty GA; Chan AK; Engstrom Y; Wright JA; Thelander L
Biochemistry; 1987 Dec; 26(24):8004-11. PubMed ID: 2827767
[TBL] [Abstract][Full Text] [Related]
18. Mammalian drug resistant mutants with multiple gene amplifications: genes encoding the M1 component of ribonucleotide reductase, the M2 component of ribonucleotide reductase, ornithine decarboxylase, p5-8, the H-subunit of ferritin and the L-subunit of ferritin.
Hurta RA; Wright JA
Biochim Biophys Acta; 1990 Oct; 1087(2):165-72. PubMed ID: 2223878
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
Cory AH; Sato A; Thompson DP; Cory JG
Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
[TBL] [Abstract][Full Text] [Related]
20. Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductase.
Li Q; Kasten-Jolly J; Yen Y; Freed BM
Toxicol Appl Pharmacol; 1998 May; 150(1):154-7. PubMed ID: 9630464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
